Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$101K Sell
11,226
-938
-8% -$6.41K ﹤0.01% 3101
2025
Q4
$66.8K Buy
12,164
+4,775
+65% +$24.6K ﹤0.01% 2758
2025
Q3
$29.5K Buy
7,389
+454
+7% +$1.91K ﹤0.01% 2264
2025
Q2
$18.8K Buy
+6,935
New +$18.4K ﹤0.01% 2173
2025
Q1
Sell
-1,852
Closed -$14.2K 2993
2024
Q4
$14.2K Buy
1,852
+21
+1% +$176 ﹤0.01% 2098
2024
Q3
$17.1K Buy
+1,831
New +$17.6K ﹤0.01% 1865
2024
Q2
Sell
-2,849
Closed -$42.2K 2381
2024
Q1
$42.2K Buy
+2,849
New +$39.7K 0.01% 1499

Other funds holding RLYB

XTX Topco's RLYB Position: Q1 2026 in Review

XTX Topco reduced its Rallybio (RLYB) stake by 7.7% in Q1 2026, selling an estimated $6.41K and leaving 11,226 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #3101.

XTX Topco first reported a position in RLYB in Q1 2024 and has held it in 7 quarters since. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • XTX Topco held 11,226 shares of Rallybio worth $101K as of Q1 2026.
  • XTX Topco sold 938 Rallybio shares in Q1 2026, an estimated $6.41K.
  • Rallybio made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3101 holding.
  • XTX Topco first reported a position in Rallybio in Q1 2024 and has held it in 7 quarters since.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.